A photo of Irina Rybalsky.

Neuromuscular Specialist, Division of Neurology

Staff Physician, Division of Neurology

513-636-4222

513-636-1888

Board Certified

About Me

Additional Languages

Russian

Clinical Divisions

Neurology, Neuromuscular Disorders

My Locations

My Publications

Age-related changes in appendicular lean mass in males with Duchenne muscular dystrophy: A retrospective review. Summer, SS; Wong, BL; Rutter, MM; Horn, PS; Tian, C; Rybalsky, I; Shellenbarger, KC; Kalkwarf, HJ. Muscle and Nerve. 2021; 63:231-238.

Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al. Osteoporosis International. 2020; 31:2449-2459.

Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Rybalsky, I; Shellenbarger, KC; Rutter, MM. Neuromuscular Disorders. 2020; 30:599-610.

Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Darmahkasih, AJ; Rybalsky, I; Tian, C; Shellenbarger, KC; Horn, PS; Lambert, JT; Wong, BL. Muscle and Nerve. 2020; 61:466-474.

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy. Naarding, KJ; Reyngoudt, H; van Zwet, EW; Hooijmans, MT; Tian, C; Rybalsky, I; Shellenbarger, KC; Le Louer, J; Wong, BL; Carlier, PG; et al. Neurology. 2020; 94:e1386-e1394.

Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy. Lambert, JT; Darmahkasih, AJ; Horn, PS; Rybalsky, I; Shellenbarger, KC; Tian, C; Wong, BL. Muscle and Nerve. 2020; 61:156-162.

Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy. Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al. Journal of Pediatrics. 2019; 210:194-200.e2.

Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity. Wasserman, HM; Hornung, LN; Stenger, PJ; Rutter, MM; Wong, BL; Rybalsky, I; Khoury, JC; Kalkwarf, HJ. Neuromuscular Disorders. 2017; 27:331-337.

Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment. Wong, BL; Rybalsky, I; Shellenbarger, KC; Tian, C; McMahon, MA; Rutter, MM; Sawnani, H; Jefferies, JL. Journal of Pediatrics. 2017; 182:296-303.e1.

Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Miller, L; Bange, J; Rybalsky, I; Rutter, MM. Neuromuscular Disorders. 2016; 26:760-767.